: #587c19; font-family: ; line-height: 30px"> Safety and effectiveness are supported by certain data
Using data to speak for strength, 4 meta-analysis to prove the efficacy and safety of vedelizumab
Time of Update: 2021-03-23
The results showed that compared with placebo, IBD patients receiving VDZ treatment achieved a higher clinical response rate (UC: RR=1.
The UK Bios sample bank publishes large-scale genetic data
Time of Update: 2021-03-14
Some of the largest data sets in the biological sample pool include genotypes and brain scans, which help promote research into genes that affect brain structure and function.
Chemogenomic Analysis of Safety Profiling Data
Time of Update: 2021-02-26
We also describe a method to quickly determine the chemical similarity of compounds active against different targets.
BMJ | Relax! Data for 440,000 people in Asia: HPV vaccine safety report
Time of Update: 2021-02-24
, a national queue study from South Korea assessed the link between HPV vaccination and adverse events among 440,000 Adolescent Girls in Asia, adding important evidence to the safety of HPV vaccines for Asian populations.
The UK Food Safety Authority updates stevia saccharide application information
Time of Update: 2020-12-31
reviewing the use of the sweetener in food. , at the suggestion of the European Commission, EU member states voted in early July on proposals to approve the application of stevia saccharides to a range of foods. proposal has now been moved
The safety of key new crown vaccine projects in the UK remains the focus
Time of Update: 2020-12-03
trials. Before AstraZeneta announced the suspension of the candidate, the vaccine had started Phase 3 clinical trials in the United States, as well as in the United Kingdom, Brazil and South Africa, and was scheduled to start clinical trials
The New Coronary Inactivated Vaccine obtained positive medium-term safety data in Phase 3 clinical trials.
Time of Update: 2020-10-28
Retrieved October 20, 2020, from the Brazilian National Health Supervision Agency approved Beijing Kexing Zhongwei Biotechnology Co., Ltd. new crown inactivated vaccine Kelleford ™️ to carry out Phase III.
National drug sharing price data sheet is being developed, to be issued as soon as possible!
Time of Update: 2020-10-28
of medical security, will rely on the platform to achieve the whole process of service management functions such as networking, bidding, procurement, trading, settlement, payment and evaluation. , it will also play the functions of scientific
Alnylam's release of long-term data on Givlaari's treatment of AHP is expected to dispel safety questions.
Time of Update: 2020-07-31
and the huge advantage of only 2 subcutaneous injections per year, the drug has a very good market penetration opportunity. Source: 1, Alnylam's RNAi the Girapy ari show lasting effect one life into treatment, new data show 2, Alnylam Reports New 12-Interim Interim Data From the Phase 3 Gevosiran in Siomh Porphyria.
EULAR Express . . . Data on the efficacy and safety of Bellitum was confirmed in the population with active lupus nephritis.
Time of Update: 2020-07-21
BLISS-LN: A randomized bi-blind control global multicenter phase III study that assessed the efficacy and safety of injectable bellicoscant sepsis for active lupus patients.